InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,224.30
(
0.06%
)
US TECH 100
17,760.20
(
0.21%
)
Dow Jones
39,426.30
(
-0.01%
)
Brent Oil
82.06
(
-1.38%
)
Bitcoin
61,819.89
(
-1.72%
)
Post# of 320
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 292

Thursday, 09/20/2012 9:53:18 AM

Thursday, September 20, 2012 9:53:18 AM

Post# of 320
8:24AM Biovest conducts meeting with EMA advancing process to seek EU approval for cancer vaccine (BVTI) 0.29 : Biovest International, majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (ABPI), reported milestone achievements advancing BiovaxID, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up